ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,194Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 1278

$897K Total Retail Price of All Prescriptions

Rank: 19 out of 1278

975 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 975 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 975 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,680 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 901 878 1 2
SIMVASTATIN 714 688 2 3
LISINOPRIL 569 564 3 1
CITALOPRAM HBR 424 402 4 22
ATORVASTATIN CALCIUM 396 379 5 15
ALENDRONATE SODIUM 346 337 6 18
METFORMIN HCL ER 319 311 7 66
CRESTOR 311 311 8 31
OMEPRAZOLE 295 282 9 6
FLUTICASONE PROPIONATE 244 235 10 24
LOSARTAN POTASSIUM 229 225 11 19
ATENOLOL 225 223 12 11
AMLODIPINE BESYLATE 223 222 13 5
METOPROLOL SUCCINATE 209 189 14 23
HYDROCHLOROTHIAZIDE 204 192 15 8
ZOLPIDEM TARTRATE 183 180 16 16
METOPROLOL TARTRATE 159 157 17 9
HYDROCODONE-ACETAMINOPHEN 156 154 S3 18 7
PRAVASTATIN SODIUM 134 117 19 14
AZITHROMYCIN 125 116 20 37
GABAPENTIN 122 107 21 12
PANTOPRAZOLE SODIUM 120 109 22 34
LOSARTAN-HYDROCHLOROTHIAZIDE 119 119 23 75
CLOPIDOGREL 109 106 24 45
WARFARIN SODIUM 104 101 25 17
CIPROFLOXACIN HCL 103 95 26 53
TRAMADOL HCL 100 84 27 25
LOVASTATIN 97 97 28 13
RANITIDINE HCL 97 84 28 20
SPIRIVA 86 86 30 65
JANUVIA 83 83 31 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 81 31 30
FUROSEMIDE 81 80 33 10
ADVAIR DISKUS 78 77 34 49
LEVOXYL 77 65 35 94
ALPRAZOLAM 74 74 36 231
POTASSIUM CHLORIDE 74 66 36 21
ZETIA 73 73 38 88
TAMSULOSIN HCL 71 71 39 32
DONEPEZIL HCL 66 66 40 48
FINASTERIDE 63 61 41 82
SYNTHROID 63 59 41 63
SERTRALINE HCL 62 61 43 28
PLAVIX 62 62 43 64
METFORMIN HCL 61 58 45 4
VENLAFAXINE HCL ER 61 57 45 121
NAMENDA 57 57 47 77
MELOXICAM 55 55 48 57
DILTIAZEM ER 52 52 49 103
ROPINIROLE HCL 52 51 49 127
SINGULAIR 51 50 51 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.